Search clinical trials for: RV521

Total 8 results

Pfizer

Completed

A Study to Learn About Effect of Sisunatovir in Healthy Adult Male Participants

Respiratory Syncytial Virus Infections

United States
Pfizer

Completed

Pharmacokinetics and Safety of RV521 Formulations (C19007)

Respiratory Syncytial Virus Infections

United Kingdom
Pfizer

Completed

A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants.

Healthy

Belgium
Pfizer

Recruiting

A Study to Learn About the Amount of the Study Medicine (Sisunatovir) in Blood and Its Safety in Infants and Children With Pneumonia Caused by RSV

Respiratory Syncytial Virus Infections

United States, Israel, Korea, Republic of, Japan, Canada
Pfizer

Completed

A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) Infection

Respiratory Syncytial Virus Infections

United Kingdom
Pfizer

Withdrawn

Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSV (REVIRAL2)

Lower Resp Tract Infection | RSV Infection | Stem Cell Transplant Complications
Pfizer

Terminated

A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection. (REVIRAL 1)

Lower Resp Tract Infection | Respiratory Syncytial Virus (RSV)

Spain, Malaysia, Israel, Hungary, Poland, Taiwan, Costa Rica, United Kingdom, Thailand, Argentina, Canada, Chile, Korea, Republic of, New Zealand, Panama
Pfizer

Completed

Drug Interaction Study With RV521 in Healthy Volunteer Subjects

Respiratory Syncytial Virus Infections

United Kingdom

Search clinical trials for: RV521

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations